Prosecution Insights
Last updated: October 25, 2026

Fasken Martineau Dumoulin, LLP (Montreal)

Technology areas: Transportation, E-Commerce & Mechanical Systems • Medical Devices & Mechanical Engineering

28 pending office actions • 14 clients • 25 examiners • 16 art units • 0 of 28 (0%) have an AI response strategy ready

Quality Metrics (n=1015 apps, methodology: how we score firms)

83.3%
Allowance Rate
n=1015
+0.56σ
Allowance Rate (norm)
n=1015
3.0
OAs to Allowance
n=564
-0.26σ
OAs to Allow (norm)
n=564
1114 days
Time to Allowance
n=564
+8.8pp
Interview Lift
n=1015
23.6%
RCE Rate
n=1015
1.0%
Appeal Rate
n=1015

Rejection Performance (% of received rejections ultimately overcome)

60.0%
§101 Overcome
n=80
73.2%
§102 Overcome
n=224
75.0%
§103 Overcome
n=376
80.3%
§112 Overcome
n=279

Specialization & Scale

A61B, G09B, G06F
Top CPC Subclasses
18%
Top-3 CPC Share
n=1015
7
Practitioners
n=1015
145.0
Apps / Practitioner
n=1015

Portfolio Summary

28
Total Pending OAs
14
Non-Final OAs
13
Final Rejections
1
Advisory / Quayle

Response Deadline Pressure

Based on the USPTO statutory response window for each pending office action. 12 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.

10
Overdue
0
Due this week
1
Due this month
0
Due in next 60 days
1
Due later

Deadline Fire Line

Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 12 of the docket's apps have a known mailing date.

-30dToday30d60d90d120d
Overdue (10)Due ≤ 30 days (1)Due later (1)

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

20
Hard (71%)
8
Medium (29%)
0
Easy (0%)
0
Unknown (0%)

Rejection Statute Mix

BucketCases
§101 + other5 (18%)
§103 only7 (25%)
Double-patenting + other1 (4%)
Multi-statute (no §101)15 (54%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

5
Life Sciences
18% of docket
2
Information Tech
7% of docket
0
Communications
0% of docket
0
Semiconductors
0% of docket
21
Mechanical / Eng
75% of docket
0
Business / Other
0% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

280 h
Manual time on pending OAs
56 h
Time saved (low, 20%)
98 h
Time saved (mid, 35%)
2.5 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
SHAH, JAY B 2 58.4% +6.0%
LIU, CHU CHUAN 2 71.3% +14.9%
CERIONI, DANIEL LEE 2 64.3% +28.0%
OGLES, MATTHEW ERIC 1 50.0% +58.4%
MORONESO, JONATHAN DREW 1 53.1% +34.8%
DAHLIN, HEATHER RAQUEL 1 42.2% +47.1%
HENSON, DEVIN B 1 65.1% +43.4%
LARGI, MATTHEW THOMAS 1 77.0% +15.6%
WANG, MICHAEL H 1 52.1% +25.5%
CORMIER, DAVID G 1 64.6% +28.7%

Hard Cases (20)

Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 8 ordered by deadline are shown.

App #TitleExaminerDue in
18047634 Handheld Oximeter with Display of Real-Time, Average Measurements and Average Resetting CERIONI, DANIEL LEE 78d overdue
18155910 METHOD FOR FACILITATING LANGUAGE LEARNING USING A TACTILE-BASED LANGUAGE LEARNING SYSTEM BODENDORF, ANDREW 73d overdue
18047640 Handheld Oximeter with Display of Real-Time, Average Measurements and Average Resetting CERIONI, DANIEL LEE 73d overdue
19291405 Oximeter with Measurement Quality Reporting LIU, CHU CHUAN 71d overdue
19248357 Oximeter with Replaceable Laparoscopic Extension HENSON, DEVIN B 42d overdue
18753986 Determining Absolute and Relative Tissue Oxygen Saturation LIU, CHU CHUAN 22d overdue
18047637 Handheld Oximeter with Display of Real-Time, Average Measurements and Status Indicator GLOVER, NELSON ALEXANDER 4d overdue
18187154 PANDEMIC RESPONSE SUPPLY CHAIN SIMULATION SYSTEM AND METHOD GUILIANO, CHARLES A 63d

Interview Candidates (11)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.

App #TitleExaminerDue in
19304725 PYRAZOLESULFONAMIDES AS ANTITUMOR AGENTS DAHLIN, HEATHER RAQUEL 81d overdue
18047634 Handheld Oximeter with Display of Real-Time, Average Measurements and Average Resetting CERIONI, DANIEL LEE 78d overdue
18047640 Handheld Oximeter with Display of Real-Time, Average Measurements and Average Resetting CERIONI, DANIEL LEE 73d overdue
19291405 Oximeter with Measurement Quality Reporting LIU, CHU CHUAN 71d overdue
19248357 Oximeter with Replaceable Laparoscopic Extension HENSON, DEVIN B 42d overdue
18753986 Determining Absolute and Relative Tissue Oxygen Saturation LIU, CHU CHUAN 22d overdue
19460172 Wireless Oxygen Saturation Sensor OGLES, MATTHEW ERIC —
19444118 Oximeter Method with Durable Unit Reuse and Sheath Disposal MORONESO, JONATHAN DREW —

Client Portfolio (14 clients)

Top Art Units

Art UnitApps
379111
17962
37152
16291
37461
36421
17111
36791
36221
36171

Pending Office Actions

App #TitleClientExaminerArt UnitStatutesStatusDue inAIFiled
19460172 Wireless Oxygen Saturation Sensor Vioptix, Inc. OGLES, MATTHEW ERIC 3791 §103 Final Rejection — Pending Jan 26, 2026
19444101 Oximeter with Replaceable Sheath and Laparoscopic Sensor Vioptix, Inc. SHAH, JAY B 3791 §102§103 Final Rejection — Pending Jan 08, 2026
19444121 Oximeter System with Durable Unit and Replaceable Sheath Vioptix, Inc. SHAH, JAY B 3791 §103 Non-Final OA — Pending Jan 08, 2026
19444118 Oximeter Method with Durable Unit Reuse and Sheath Disposal Vioptix, Inc. MORONESO, JONATHAN DREW 3791 §103§112Other Non-Final OA — Pending Jan 08, 2026
19304725 PYRAZOLESULFONAMIDES AS ANTITUMOR AGENTS Peloton Therapeutics, Inc., A Fully Owned Subsidiary Of Merck Sharp & Dohme LLC DAHLIN, HEATHER RAQUEL 1629 §103 Final Rejection 81d overdue Pending Aug 20, 2025
19291405 Oximeter with Measurement Quality Reporting Vioptix, Inc. LIU, CHU CHUAN 3791 §101§103§112DP Final Rejection 71d overdue Pending Aug 05, 2025
19248357 Oximeter with Replaceable Laparoscopic Extension Vioptix, Inc. HENSON, DEVIN B 3791 §102§103 Non-Final OA 42d overdue Pending Jun 24, 2025
19196945 AMMONIA GASIFIER FOR A SELECTIVE CATALYTIC REDUCTION DEVICE, AND ASSOCIATED SYSTEMS AND METHODS Safety Power Inc. LARGI, MATTHEW THOMAS 3746 §103§112 Final Rejection — Pending May 02, 2025
19079654 ANIMAL DENTAL HYGIENIC DEVICE WITH ELONGATED PORTION Nathalie Fiset WANG, MICHAEL H 3642 §102§103§112 Final Rejection — Pending Mar 14, 2025
19042832 MACHINE AND METHOD FOR CLEANING LENSES, LIKE EYEGLASS LENSES Mei S.r.l. CORMIER, DAVID G 1711 §102§103§112 Non-Final OA — Pending Jan 31, 2025
19028866 CONNECTOR ASSEMBLY North America Elevate Healthcare Human Capital Inc. BINDA, GREGORY JOHN 3679 §102§103 Non-Final OA — Pending Jan 17, 2025
19016856 SYSTEM AND METHOD FOR DETERMINING EXPECTED LOSS USING A MACHINE LEARNING FRAMEWORK The Toronto-Dominion Bank GIERINGER, MELINDA J 3622 §101§112 Final Rejection — Pending Jan 10, 2025
18943799 Probe Tip Assembly and Bezel for Medical Device Vioptix, Inc. MUSTANSIR, ABID A 3791 §103DP Non-Final OA — Pending Nov 11, 2024
18912705 OFF-ROAD VEHICLE BOMBARDIER INC. WILHELM, TIMOTHY 3617 §102§103 Non-Final OA — Pending Oct 11, 2024
18912883 FRAME ASSEMBLY FOR AN OFF-ROAD VEHICLE BOMBARDIER INC. ARCE, MARLON ALEXANDER 3611 §102§103 Non-Final OA — Pending Oct 11, 2024
18844067 COMPOUNDS FOR THE MEASUREMENT OF THE OXYGEN CONCENTRATION Center For Neuromusculoskeletal Restorative Medicine Limited MOSHER, ERIC PARKER 1612 §101§103§112 Non-Final OA — Pending Sep 05, 2024
18796138 NFC Security for Medical Device and Sheath Vioptix, Inc. LANE, GREGORY A 2438 §103 Final Rejection 85d overdue Pending Aug 06, 2024
18753986 Determining Absolute and Relative Tissue Oxygen Saturation Vioptix, Inc. LIU, CHU CHUAN 3791 §103§112 Final Rejection 22d overdue Pending Jun 25, 2024
18705013 DEVICES AND METHODS FOR ELECTROMAGNETIC SENSING OF LATERAL FLOW ASSAYS 11281232 Canada Inc. HYUN, PAUL SANG HWA 1796 §102§103§112 Non-Final OA — Pending Apr 26, 2024
18498746 SYSTEMS AND METHODS FOR IMPROVED METABOLOMICS Ai-Genetika Inc. SINES, BRIAN J 1796 §102§103 Non-Final OA — Pending Oct 31, 2023
18213624 MULTIVARIATE TIME SERIES FORECASTER USING DEEP LEARNING The Toronto-Dominion Bank KEATON, SHERROD L 2148 §103Other Non-Final OA — Pending Jun 23, 2023
18192418 AUGMENTED REALITY HOIST TRAINING SYSTEM Cae Inc. UTAMA, ROBERT J 3715 §103 Final Rejection 114d overdue Pending Mar 29, 2023
18187298 SUPPLY AND LOGISTICS MODELLING SYSTEM FOR PANDEMIC RESPONSE Logistics And Supply Chain Multitech R&D Centre Limited RINES, ROBERT D 3625 §103 Non-Final OA 28d Pending Mar 21, 2023
18187154 PANDEMIC RESPONSE SUPPLY CHAIN SIMULATION SYSTEM AND METHOD Logistics And Supply Chain Multitech R&D Centre Limited GUILIANO, CHARLES A 3623 §101§103 Final Rejection 63d Pending Mar 21, 2023
18155910 METHOD FOR FACILITATING LANGUAGE LEARNING USING A TACTILE-BASED LANGUAGE LEARNING SYSTEM The Education University of Hong Kong BODENDORF, ANDREW 3715 §101§102§103§112 Final Rejection 73d overdue Pending Jan 18, 2023
18047640 Handheld Oximeter with Display of Real-Time, Average Measurements and Average Resetting Vioptix, Inc. CERIONI, DANIEL LEE 3791 §103§112 Final Rejection 73d overdue Pending Oct 18, 2022
18047637 Handheld Oximeter with Display of Real-Time, Average Measurements and Status Indicator Vioptix, Inc. GLOVER, NELSON ALEXANDER 3791 §103§112 Non-Final OA 4d overdue Pending Oct 18, 2022
18047634 Handheld Oximeter with Display of Real-Time, Average Measurements and Average Resetting Vioptix, Inc. CERIONI, DANIEL LEE 3791 §103§112 Non-Final OA 78d overdue Pending Oct 18, 2022

Managing Fasken Martineau Dumoulin, LLP (Montreal)'s Patent Prosecution?

IP Author helps law firms respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Frequently Asked Questions

What is Fasken Martineau Dumoulin, LLP (Montreal)'s patent allowance rate?

83.3% of resolved applications prosecuted by Fasken Martineau Dumoulin, LLP (Montreal) were allowed, across 1,015 applications in USPTO records.

How many office actions does Fasken Martineau Dumoulin, LLP (Montreal) average before allowance?

2.95 office actions per allowed application on average.

How many pending office actions does Fasken Martineau Dumoulin, LLP (Montreal) have?

28 pending office actions as of October 2026, for 14 clients, before 25 examiners in 16 art units.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month